+86-571-8627 3270
Jinan Hongwan Biotechnology Co.,Ltd.
Shandong, China
CNY 10 Million
99900 m²
Less than 50 people
Main Products: Tildenafil / Favipiravir / Cetilistat / Gefitinib
Shandong, China
ABOUT US
Jinan Hongwan Biotechnology Co., Ltd. Jinan Hongwan Biotechnology Co., Ltd. (hereinafter referred to as "Hongwan technology") and natural person shareholders jointly initiated and incorporated, with a registered capital of 10 million yuan. Hongwan technology is a supplier of pharmaceutical intermediates and APIs for several large pharmaceutical enterprises in China, and has established a cooperation mode of joint research and development and supporting production with Qilu pharmaceutical. Focusing on the development of advanced pharmaceutical intermediates and new biomedical materials industry, the company is a strategic platform for Hongwan science and technology to develop new drug R & D, intermediates and API production. It will be committed to the R & D of new drugs, the production of pharmaceutical intermediates and APIs and the operation of relevant industrial chains.The company's R & D ability and management level are outstanding. In addition, relying on scientific research platforms such as Oxford University, Qilu University of technology, Shandong Academy of Sciences, Qilu Pharmaceutical Co., Ltd. and Shandong Academy of Pharmaceutical Sciences, the R & D center has many high-level R & D personnel, which can fully meet the needs of the company's current R & D work. It has 1000 square meters of organic synthesis laboratory and complete testing instruments.The company is in a period of rapid development. It keeps in touch with many domestic universities and establishes close industry university research cooperation with Shandong University, Qilu University of Technology (Shandong Academy of Sciences) and other universities and scientific research institutes. It will provide products for the above-mentioned universities for scientific research and exploration, and establish cooperative relations of project collaborative transformation.
Basic Information
Tax ID
91370126MA3M1CCL9E
Country/Region
Shandong, China
Year Established
2018
Registered Capital
CNY 10 Million
Business Type
Manufacturing
Total Employees
Less than 50 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
The company focuses on the development of advanced pharmaceutical intermediates and new biomedical materials
PLANT LOCATION
COMPANY ALBUM
生产车间
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >